Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCTs041250105) titled 'Pharmacokinetics and safety of LC2701 administered once to healthy adult male subjects' on Sept. 29.
Study Type: Interventional
Study Design:
single arm study, open(masking not used), historical control, single assignment, treatment purpose
Primary Sponsor: Yamamoto Yoshihiro
Condition:
Healthy adult male
Intervention:
Study Drug Application for Subjects
Phase I: Apply one LC2701 patch for 24 hours on Day 1. Washout Period: At least 7 days. Phase II: Apply two LC2701 patches for 24 hours on Day 1. The study drug will be applied to the left chest in Phase I and to the right chest in Phase II....
Recruit...